NERV

Minerva Neurosciences INC

+$123.1M

Net Activity

Institutions Holding

44

Popularity Rank

#6307

Avg Weight

0.51%

Total Value

$230.8M

Ownership Trend

44 institutions currently hold NERV, with 24 net buyers and 11 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

11

Net Buying Institutions

24

Key Holders

View all 44 holding institutions

Quarterly Activity

Recent Activity

+$107.9M

Total Buy Value

$45.2M

Total Sell Value

New buy16
Trim8
Add8
Sold out3

24

Net Buyers

11

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

1

Active 5%+ Holders

Data as of 2026-07-08
Reporting PersonTypeFiling Date% of Class
Federated Hermes, Inc.13G/A2026-07-0817.2%

View all Schedule 13D/13G filings

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding MINERVA NEUROSCIENCES INC (NERV)?
Major stakeholders currently include Federated Hermes, INC. ($30.8M), Vivo Capital, LLC ($26.0M), Janus Henderson Group PLC ($25.9M). Based on the latest 13F filings, there are a total of 44 tracked investment funds and institutions maintaining positions in NERV.
What is the overall institutional sentiment toward NERV recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $123.1M, driven by 24 managers accumulating shares while 11 reduced their exposure.
Which institutions have been selling or reducing their NERV positions?
In the latest period, 8 funds trimmed their holdings, and 3 managers completely exited their positions. The aggregate reported sell value was $45.2M.
Are there any notable investors adding NERV to their portfolios?
Yes, buying activity remains notable. 16 institutions opened new positions in {ticker}, and 8 existing holders added to their shares. The total reported buy value for the quarter amounted to $107.9M.

Related Stocks